Search for the latest oncology news by tumour type
Links between metabolism and aggressive breast cancer
Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer, and TNBC patients…
Browsing: Tumour Stream
New explanation for how cancer drugs destroy BRCA1 and BRCA2 tumour cells
Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses…
Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Centre, USA, demonstrated the potential of…
Study identifies immune response that may stop breast cancer from spreading
A new Moffitt Cancer Centre study has identified a specific immune response that may prevent…
NICE recommends lisocabtagene maraleucel cell therapy for eligible patients with relapsed or refractory large B-cell lymphomas
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Massive data analysis advances the understanding of how immunotherapy works
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder…
New hope for colorectal cancer treatment: Innovative CE6-GFFY photosensitiser
Many strategies have been employed for clinical colorectal cancer (CRC) therapy. However, current treatments face significant…
Can exercise help colon cancer survivors live as long as matched individuals in the general population?
Physical activity may help colon cancer survivors achieve long-term survival rates similar to those of…
ASCO GU 2025: New findings on tumour reduction and survival outcomes in advanced renal cell carcinoma
Thomas E. Hutsonchief of the Haematology Oncology Division at Texas Tech University Health Sciences Centre,…
Article details drug’s lack of benefit for head and neck cancer
A physician-scientist at the University of Oklahoma, USA, is part of an international effort seeking…